Premium
Genta Incorporated (MM) (GNTAD)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
-- New Phase 3 trial of Genasense(R) seeks to confirm benefit in melanoma BERKELEY HEIGHTS, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) today announced financial...
BERKELEY HEIGHTS, N.J., Aug. 2 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) announced that the Company will release its second quarter 2007 financial results on Tuesday, August 7...
BERKELEY HEIGHTS, N.J., July 30 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) announced today that the Company has been formally notified by NASDAQ that it has demonstrated...
AGENDA Trial Set to Confirm Findings in Marketing Application BERKELEY HEIGHTS, N.J., July 19 /PRNewswire-FirstCall/ -- Genta Incorporated (NASDAQ:GNTAD) announced today that it has received...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
